BGL, a founding sponsor of the original DxPx Conference, is proud to help bring the partnering conference to the U.S. this summer. Like its sister conference in Germany, DxPx U.S. is designed to facilitate licensing, financing, co-development, and M&A opportunities. The conference’s concept was founded by startup founders and former industry executives who recognized a need for a dedicated diagnostic and research tool-focused platform.
This year’s first ever DxPx Conference in the U.S. runs from July 27-31, 2021, and brings together growth companies as well as established industry companies and investors in the Dx space.
BGL’s Diagnostics, Research Tool & Device team has decades of experience advising all major subsectors of the Diagnostics & Research Tools industry. We maintain active relationships with global industry participants and capital providers, and follow regulatory and reimbursement trends; this enables us to not only provide unique access to capital providers, but also the ability to identify and execute on strategic opportunities for our clients.
“After two very successful DxPx Conferences in Europe, we are excited to bring the concept to the US for the first time. DxPx is the only partnering event dedicated to diagnostics, precision medicine and research tools, and we look forward to meeting with industry participants and participation in compelling panel discussions” – Christoph Brandenberger, BGL Managing Director